Skip to main page content

Dr. Jacinthe Rouleau

2023 Planning Committee - Neuro-Ophthalmology
University of Montréal CHUM
Participates in 5 items

Bio Jacinthe Rouleau, MD  FRCSC

 

Dr. Jacinthe Rouleau is an ophthalmologist and surgeon at theCentre Hospitalier de l’Université de Montréal (CHUM). In addition to being an associate clinical professor at the University of Montreal, she also holds the title of head of the neuro-ophthalmology division.

After obtaining her medical degree at Laval University, Dr. Rouleau completed her residency in ophthalmology at the University of Montreal. She then continued her training with an additional fellowship year in neuro-ophthalmology at the Department of Ophthalmology and Visual Science at the University of Iowa, in the United States.

In addition to neuro-ophthalmology, she practices general ophthalmology and has an interest for cataracts and glaucoma.


Her neuro-ophthalmology clinics are mainly at the CHUM, where she is involved in the training of residents and medical students. Dr. Rouleau also contributes to continuing education; she is regularly invited as a lecturer in various national and international meetings, not only for ophthalmologists but also for other health professionals (optometrists, family doctors and medical specialists).

Sessions in which Dr. Jacinthe Rouleau participates

Friday 16 June, 2023

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
8:00 AM
8:00 AM - 10:00 AM | 2 hours
Current Concepts

 Learning Objectives:At the end of this session, participants will be able to:Review how to apply Quality Improvement strategies to improve patient safetyBe familiar with the presentation and histology of hereditary benign intraepithelial dyskeratosis, and be able to distinguish it from other conjunctival lesions including conjunctival intraepithelial neoplasia.Des...

10:45 AM
10:45 AM - 10:47 AM | 2 minutes
10:45 AM - 12:15 PM | 1 hour 30 minutes
Neuro-ophthalmology

 Learning Objectives: At the end of this session, participants will be able to: Describe the presenting signs and symptoms, as well as evaluation and management of Giant Cell ArteritisExplain the therapeutic options for central retinal artery occlu...

1:30 PM
1:30 PM - 3:00 PM | 1 hour 30 minutes
Neuro-ophthalmology

 Learning Objectives: At the end of this session, participants will be able to: Explain the mechanism of action of the major immune checkpoint inhibitors currently used in cancer immunotherapyDiscuss the